3,791 companies
2,399 AI summaries
1,857 risk analyses
1,326 growth scores
Register free — watchlist & alerts →
🔔 Get free email alerts on FUJI LATEX CO.,LTD. (5199)
AI summaries of Japanese EDINET filings — in English. Free, unsubscribe anytime.
- ✓ Email alert when 5199 files its next EDINET disclosure
- ✓ AI summary · sentiment · risk · growth (JA / EN)
- ✓ Free account: watchlist & alerts on all the stocks you follow
EDINET 5199 Positive Risk Analyzed 📈 Growth 6/10
FUJI LATEX CO.,LTD.
Annual Securities Report - 78th Term(2025/04/01 - 2026/03/31) ／ 2026-06-23 11:00
Covers EDINET statutory filings (TDNET timely disclosures / earnings flashes are not included).
EarningsGuidance UpRestructuringCapacityMarginNew ProductPricing
AI Summary
2026-06-23 11:06
Structural reform in medical device business (condom manufacturing halt, factory consolidation) offset by strong precision instruments. FY2026 guidance: revenue +10.3%, OP +15.4%, NI +351.0%.
KEY POINTS
- Operating profit surged 99.4% (¥208M → ¥415M), profit margin improved significantly
- Precision instruments business drove sales +8.1%, order backlog +17.8%
- Medical device restructuring underway; major improvement expected FY2026
- FY2026 guidance: Revenue +10.3%, OP +15.4%, NI +351.0%
📊 Revenue
Revenue -5.6% (¥6,798M, down ¥400M YoY)
💰 Operating profit
Operating profit +99.4% (¥415M, up ¥207M YoY)
🔮 Outlook
FY2026: Revenue +10.3%, OP +15.4%, NI +351.0% expected. Efficiency gains from factory consolidation and continued precision instruments strength.
📈 Growth outlook
📈 Growth 6/10
Medium-term plan execution and factory consolidation efficiency gains support significant profit recovery in FY2026. However, structural revenue headwind from condom business discontinuation persists.
Growth drivers
- Precision instruments order growth and sales momentum (+8.1%, backlog +17.8%)
- Cost reduction and efficiency gains from medical-device factory consolidation
- Price optimization following factory integration
- Next-generation manufacturing capability from new facility investment
Risk and growth scores and tags are AI-generated estimates from analyzing the disclosure. They are not guarantees of fact, nor investment advice or recommendations. Make investment decisions at your own discretion.
⚠️ Extracted Risk Factors
| Category | Description | Score | New |
|---|---|---|---|
| Market Risk | Condom market shrinking due to aging population; new product delays hinder recovery. | 7/10 | |
| Supply Chain Risk | Production concentrated in Tochigi; major earthquake/disaster risk could disrupt operations. Aging facilities at higher risk. | 7/10 | |
| Raw Material Risk | Strong upward pressure on silicone oil, resins, natural rubber. Limited pricing power for pass-through. | 6/10 | |
| Interest Rate Risk | Relatively high debt-to-equity ratio. Rising rates would materially impact earnings. | 6/10 | |
| Regulatory Risk | Medical products subject to PMDA approval. Regulatory withdrawal or denial could halt business. | 6/10 | |
| Climate Change Risk | Carbon tax/emissions trading in 1.5°C scenario increases procurement and logistics costs. Decarbonization investment required. | 5/10 | |
| Talent Risk | Succession planning for long-developed technical expertise challenging. Labor availability key constraint. | 5/10 | |
| Intellectual Property Risk | Complex multi-faceted IP portfolio. Risk of third-party infringement litigation; counterfeit prevention challenging. | 4/10 |
7/10
Market Risk
Condom market shrinking due to aging population; new product delays hinder recovery.
7/10
Supply Chain Risk
Production concentrated in Tochigi; major earthquake/disaster risk could disrupt operations. Aging facilities at higher risk.
6/10
Raw Material Risk
Strong upward pressure on silicone oil, resins, natural rubber. Limited pricing power for pass-through.
6/10
Interest Rate Risk
Relatively high debt-to-equity ratio. Rising rates would materially impact earnings.
6/10
Regulatory Risk
Medical products subject to PMDA approval. Regulatory withdrawal or denial could halt business.
5/10
Climate Change Risk
Carbon tax/emissions trading in 1.5°C scenario increases procurement and logistics costs. Decarbonization investment required.
5/10
Talent Risk
Succession planning for long-developed technical expertise challenging. Labor availability key constraint.
4/10
Intellectual Property Risk
Complex multi-faceted IP portfolio. Risk of third-party infringement litigation; counterfeit prevention challenging.
Track Japanese disclosures with JSIGNAL
AI summaries, risk & growth analysis, watchlist alerts and a screener for every Japanese listed company.
Start free — 30-day trial Login